SPRY2 and colorectal neoplasm: Taken together, this is the first study to our knowledge to demonstrate that putative CTCF binding regulatory regions #1 and #4 are mostly hypomethylated in colorectal tumors, which correlates with overall increased SPRY2 protein expression.